1Carleton SM,Peck DS ,Grasela J,et al. DNA carrier testing and newborn screening for maple syrup urine disease in Old Order Mennonite communities [ J ]. Genet Test Mol Biomarkers,2010, 14(2) :205-208.
2Menkes JH, Hurst PL, Craig JM. A new syndrome:progressive familial infantile cerebral dysfunction associated with an unusual urinary substance [ J ]. Pediatrics, 1954,14 ( 5 ) :462-467.
3Chuang DT, Shih VE. Maple syrup urine disease (branched- chain ketoaciduria)//Scriver CR, Beaudet AL, Sly WS, et al. The Metabolic and Molecular Bases of Inherited Disease [M ]. New York, NY : McGraw-Hill,2001 : 1971-2006.
4Wang J,Liu H,Chen G,et al. Identification of two novel BCK- DHA mutations in a Chinese patient with maple syrup urine dis- ease [ J ]. J Pediatr Endocrinol Metab, 2011,24 ( 9-10 ) : 827- 829.
5Zinnanti WJ, Lazovic J. Interrupting the mechanisms of brain in- jury in a model of maple syrup urine disease encephalopathy [J]. J Inherit Metab Dis,2012,35 ( 1 ) :71-79.
6Fern6ndez-Guerra P, Navarrete R, Weisiger K, et al. Functional characterization of the novel intronic nucleotide change c. 288 + 9C > T within the BCKDHA gene :understanding a variant pres- entation of maple syrup urine disease[J]. J Inherit Metab Dis, 2010,33( Suppl 3) :S191-198.
7Oyarzabal A, Martinez-Pardo M, Merinero B, et al. A Novel regulatory defect in the branched-chain alpha-ketoacid dehydro- genase complex due to a mutation in the PPM1K gene causes amild variant phenotype of maple syrup urine disease [J ]. Hum Mutat,2013,34(2) :355-362.
8Chace DH,Kalas TA. A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing [ J ]. Clin Biochem,2005,38 ( 4 ) :296 -309.
9Dixon M. Maple Syrap Urine Disease//Shaw V, Lawson M. Clinical Paediatric Dietetics [ M ]. 3rd ed. Hoboken: Blackwell Pub ,2007:332-229.
10Dionisi-Vici C, Ogier de Banlny H. Emergency Treatments// Saudubray JM, Van Den Berghe G, Walter JH, et al. Inborn Metabolic Diseases: Diagnosis and Treatment [ M ]. 5 th ed. New York, NY : Springer ,2012 : 103-1 10.
